Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

RRI as Diagnostic and Follow up Indicator in Cirrhosis of the Liver with Hepatorenal Syndrome and Refractory Ascites.

C AK, L P, Krishnamurthy A.

J Assoc Physicians India. 2019 Apr;67(4):22-25.

PMID:
31299833
2.

New Developments in Hepatorenal Syndrome.

Mindikoglu AL, Pappas SC.

Clin Gastroenterol Hepatol. 2018 Feb;16(2):162-177.e1. doi: 10.1016/j.cgh.2017.05.041. Epub 2017 Jun 7. Review. Erratum in: Clin Gastroenterol Hepatol. 2018 Jun;16(6):988.

3.

Diagnosis and therapy of ascites in liver cirrhosis.

Biecker E.

World J Gastroenterol. 2011 Mar 14;17(10):1237-48. doi: 10.3748/wjg.v17.i10.1237.

4.

[Hepatorenal syndrome].

Mijac D, Kezić A, Stojimirović B.

Srp Arh Celok Lek. 2007 Jan-Feb;135(1-2):98-104. Review. Serbian.

5.

Management of hepatorenal syndrome in patients with cirrhosis.

Arroyo V, Fernández J.

Nat Rev Nephrol. 2011 Aug 9;7(9):517-26. doi: 10.1038/nrneph.2011.96. Review.

PMID:
21826080
6.

Renal duplex Doppler ultrasound in patients with HCV related liver cirrhosis.

Fouad YM, Mokarrab H, Elgebaly AF, El-Amin H, Abdel-Raheem EM, Sharawy MA, Shatat ME.

Trop Gastroenterol. 2009 Oct-Dec;30(4):213-8.

PMID:
20426281
7.

[Hepatorenal syndrome in decompensated cirrhosis : A special form of acute renal failure].

Lenz K, Buder R, Lohr G, Piringer P, Voglmayr M.

Med Klin Intensivmed Notfmed. 2016 Jun;111(5):440-6. doi: 10.1007/s00063-016-0177-5. Epub 2016 May 30. Review. German.

PMID:
27241778
9.

Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.

Testino G, Ferro C, Sumberaz A, Messa P, Morelli N, Guadagni B, Ardizzone G, Valente U.

Hepatogastroenterology. 2003 Nov-Dec;50(54):1753-5.

PMID:
14696397
10.
11.
12.
13.

Hepatorenal syndrome and novel advances in its management.

Fabrizi F, Aghemo A, Messa P.

Kidney Blood Press Res. 2013;37(6):588-601. doi: 10.1159/000355739. Epub 2013 Dec 5. Review.

14.

Management of ascites and hepatorenal syndrome.

Piano S, Tonon M, Angeli P.

Hepatol Int. 2018 Feb;12(Suppl 1):122-134. doi: 10.1007/s12072-017-9815-0. Epub 2017 Aug 23. Review.

PMID:
28836115
15.

Incidence and characteristics of type 2 hepatorenal syndrome in patients with cirrhosis and refractory ascites.

Sersté T, Lebrec D, Valla D, Moreau R.

Acta Gastroenterol Belg. 2008 Jan-Mar;71(1):9-14.

PMID:
18396743
16.

Fluid retention in cirrhosis: pathophysiology and management.

Kashani A, Landaverde C, Medici V, Rossaro L.

QJM. 2008 Feb;101(2):71-85. doi: 10.1093/qjmed/hcm121. Epub 2008 Jan 9. Review.

PMID:
18184668
17.

[Hepatorenal syndrome: diagnosis, treatment and prevention].

Egerod Israelsen M, Gluud LL, Bendtsen F, Møller S, Krag AA.

Ugeskr Laeger. 2013 May 27;175(22):1562-6. Review. Danish.

PMID:
23721840
18.

The clinical management of abdominal ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: a review of current guidelines and recommendations.

Pericleous M, Sarnowski A, Moore A, Fijten R, Zaman M.

Eur J Gastroenterol Hepatol. 2016 Mar;28(3):e10-8. doi: 10.1097/MEG.0000000000000548. Review.

PMID:
26671516
19.

Terlipressin Plus Albumin Is More Effective Than Albumin Alone in Improving Renal Function in Patients With Cirrhosis and Hepatorenal Syndrome Type 1.

Boyer TD, Sanyal AJ, Wong F, Frederick RT, Lake JR, O'Leary JG, Ganger D, Jamil K, Pappas SC; REVERSE Study Investigators.

Gastroenterology. 2016 Jun;150(7):1579-1589.e2. doi: 10.1053/j.gastro.2016.02.026. Epub 2016 Feb 16.

PMID:
26896734
20.

Hepatorenal syndrome.

Biswas KD, Jain AK.

Trop Gastroenterol. 2002 Jul-Sep;23(3):113-6. Review.

PMID:
12693150

Supplemental Content

Support Center